Trading Signals: BCRX Stock Price Prediction and Forecast (Tue. Sep. 2, 2003 - Wed. Sep. 27, 2023)(BioCryst Pharmaceuticals, Inc.)
| BCRX latest price $5.4300 (-1.54%) ($5.3700 - $6.2860) on Tue. May. 12, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 9.89% (three month average) | RSI | 73 | Latest Price | $5.4300(-1.54%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | BCRX advances 6.6% a day on average for past five trading days. | Weekly Trend | BCRX advances 17.9% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support BCRX advance at 0% a week (0% probability) IYT(8%) XLC(7%) UUP(5%) IGOV(4%) TBT(4%) | Factors Impacting BCRX price | BCRX will decline at least -4.945% in a week (0% probabilities). EWP(-6%) TLT(-5%) ONLN(-5%) GDXJ(-5%) VIXM(-4%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | | | | Market Trend Strength | -4.945% (StdDev 9.89%) | Hourly BBV | 0.7 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $4.67(16.27%) | 10 Day Moving Average | $4.27(27.17%) | 20 Day Moving Average | $3.78(43.65%) | To recent high | -1.5% | To recent low | 0% | Market Cap | $958m | | | | BioCryst Pharmaceuticals, Inc. designs and develops novel, oral and small-molecule medicines. Its drug candidates include Berotralstat, BCX9930, BCX9250, RAPIVAB, ALPIVAB, RAPIACTA, PERAMIFLU, Galidesivir and Mundesine. The company was founded in 1986 and is headquartered in Durham, NC. |